Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | Pla2g12b (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of PLA2G12B mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | affects expression | ISO | Pla2g12b (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of PLA2G12B mRNA | CTD | PMID:17555576 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of PLA2G12B mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PLA2G12B mRNA | CTD | PMID:20106945 and PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PLA2G12B mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | PLA2G12B (Homo sapiens) | 6480464 | [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PLA2G12B mRNA | CTD | PMID:26159488 | 4-hydroxyphenyl retinamide | increases expression | ISO | Pla2g12b (Mus musculus) | 6480464 | Fenretinide results in increased expression of PLA2G12B mRNA | CTD | PMID:28973697 | aflatoxin B1 | affects expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of PLA2G12B protein | CTD | PMID:20106945 | aflatoxin B1 | increases expression | ISO | Pla2g12b (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of PLA2G12B mRNA | CTD | PMID:19770486 | aldehydo-D-glucose | multiple interactions | ISO | Pla2g12b (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PLA2G12B mRNA | CTD | PMID:37567420 | benzo[a]pyrene | decreases expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of PLA2G12B mRNA | CTD | PMID:32234424 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of PLA2G12B mRNA | CTD | PMID:25181051 | bisphenol A | decreases methylation | ISO | PLA2G12B (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of PLA2G12B gene | CTD | PMID:31601247 | bisphenol A | increases expression | ISO | Pla2g12b (Mus musculus) | 6480464 | bisphenol A results in increased expression of PLA2G12B mRNA | CTD | PMID:34585602 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PLA2G12B mRNA | CTD | PMID:32145629 | bisphenol A | affects expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | bisphenol A affects the expression of PLA2G12B mRNA | CTD | PMID:30903817 | cadmium dichloride | increases expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of PLA2G12B mRNA | CTD | PMID:21457566 | CGP 52608 | multiple interactions | ISO | PLA2G12B (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to PLA2G12B gene] | CTD | PMID:28238834 | copper(II) sulfate | decreases expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of PLA2G12B mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of PLA2G12B mRNA | CTD | PMID:20106945 more ... | D-glucose | multiple interactions | ISO | Pla2g12b (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PLA2G12B mRNA | CTD | PMID:37567420 | dextran sulfate | multiple interactions | ISO | Pla2g12b (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PLA2G12B mRNA | CTD | PMID:29950665 | dicrotophos | decreases expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of PLA2G12B mRNA | CTD | PMID:28302478 | endosulfan | multiple interactions | ISO | PLA2G12B (Homo sapiens) | 6480464 | [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PLA2G12B mRNA | CTD | PMID:26159488 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of PLA2G12B mRNA | CTD | PMID:29391264 | folic acid | increases expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | Folic Acid results in increased expression of PLA2G12B mRNA | CTD | PMID:21867686 | fonofos | increases methylation | ISO | PLA2G12B (Homo sapiens) | 6480464 | Fonofos results in increased methylation of PLA2G12B promoter | CTD | PMID:22847954 | fructose | multiple interactions | ISO | Pla2g12b (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PLA2G12B mRNA | CTD | PMID:37567420 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of PLA2G12B mRNA | CTD | PMID:33387578 | glucose | multiple interactions | ISO | Pla2g12b (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PLA2G12B mRNA | CTD | PMID:37567420 | GW 4064 | increases expression | ISO | Pla2g12b (Mus musculus) | 6480464 | GW 4064 results in increased expression of PLA2G12B mRNA | CTD | PMID:26655953 | menadione | affects expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of PLA2G12B mRNA | CTD | PMID:20044591 | methylmercury chloride | increases expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of PLA2G12B mRNA | CTD | PMID:28001369 | monosodium L-glutamate | multiple interactions | ISO | Pla2g12b (Mus musculus) | 6480464 | [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of PLA2G12B mRNA | CTD | PMID:20111022 | nitrofen | increases expression | EXP | | 6480464 | nitrofen results in increased expression of PLA2G12B mRNA | CTD | PMID:33484710 | O-methyleugenol | decreases expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | methyleugenol results in decreased expression of PLA2G12B mRNA | CTD | PMID:32234424 | paracetamol | decreases expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of PLA2G12B mRNA | CTD | PMID:29067470 | parathion | increases methylation | ISO | PLA2G12B (Homo sapiens) | 6480464 | Parathion results in increased methylation of PLA2G12B promoter | CTD | PMID:22847954 | perfluorononanoic acid | decreases expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of PLA2G12B mRNA | CTD | PMID:32588087 | perfluorooctanoic acid | decreases expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of PLA2G12B protein | CTD | PMID:26879310 | potassium dichromate | increases expression | ISO | Pla2g12b (Mus musculus) | 6480464 | Potassium Dichromate results in increased expression of PLA2G12B mRNA | CTD | PMID:23608068 | quercetin | decreases expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | Quercetin results in decreased expression of PLA2G12B mRNA | CTD | PMID:21632981 | resveratrol | multiple interactions | ISO | PLA2G12B (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of PLA2G12B mRNA | CTD | PMID:23557933 | sodium arsenite | decreases expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of PLA2G12B mRNA | CTD | PMID:29301061 | sodium arsenite | decreases expression | ISO | Pla2g12b (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of PLA2G12B mRNA | CTD | PMID:37682722 | tamoxifen | affects expression | ISO | Pla2g12b (Mus musculus) | 6480464 | Tamoxifen affects the expression of PLA2G12B mRNA | CTD | PMID:17555576 | terbufos | increases methylation | ISO | PLA2G12B (Homo sapiens) | 6480464 | terbufos results in increased methylation of PLA2G12B promoter | CTD | PMID:22847954 | Theaflavin 3,3'-digallate | affects expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | theaflavin-3 and 3'-digallate affects the expression of PLA2G12B mRNA | CTD | PMID:34925699 | titanium dioxide | multiple interactions | ISO | Pla2g12b (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PLA2G12B mRNA | CTD | PMID:29950665 | valproic acid | affects expression | ISO | Pla2g12b (Mus musculus) | 6480464 | Valproic Acid affects the expression of PLA2G12B mRNA | CTD | PMID:17963808 | valproic acid | decreases expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of PLA2G12B mRNA | CTD | PMID:29154799 | valproic acid | affects expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | Valproic Acid affects the expression of PLA2G12B mRNA | CTD | PMID:25979313 | vanadyl sulfate | increases expression | ISO | PLA2G12B (Homo sapiens) | 6480464 | vanadyl sulfate results in increased expression of PLA2G12B mRNA | CTD | PMID:16330358 | zinc atom | multiple interactions | ISO | PLA2G12B (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of PLA2G12B mRNA | CTD | PMID:18593933 | zinc(0) | multiple interactions | ISO | PLA2G12B (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of PLA2G12B mRNA | CTD | PMID:18593933 | |